InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in InflaRx N.V. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +3 vs. Q3 2021
- Shares held
- 9.27M
- +396.3K (+4.5%) vs. Q3 2021
- Total value
- $44.1M
- +$21.1M (+91.9%) vs. Q3 2021
- New holders
- 11
- 6 more added
- Sold out
- 8
- 10 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IFRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 62 | $211.6M |
| Q1 2026 | 35 | $16.9M |
| Q4 2025 | 34 | $19.6M |
| Q3 2025 | 27 | $24.9M |
| Q2 2025 | 27 | $13.3M |
| Q1 2025 | 31 | $17.9M |
| Q4 2024 | 30 | $32.1M |
| Q3 2024 | 27 | $19.7M |
| Q2 2024 | 33 | $23.0M |
| Q1 2024 | 37 | $21.3M |
| Q4 2023 | 39 | $27.8M |
| Q3 2023 | 42 | $56.8M |
| Q2 2023 | 37 | $82.7M |
| Q1 2023 | 25 | $7.08M |
| Q4 2022 | 33 | $11.6M |
| Q3 2022 | 30 | $10.5M |
| Q2 2022 | 27 | $7.63M |
| Q1 2022 | 32 | $12.0M |
| Q4 2021 | 38 | $44.1M |
| Q3 2021 | 35 | $23.0M |
| Q2 2021 | 37 | $33.1M |
| Q1 2021 | 42 | $56.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding InflaRx N.V.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 3,285,000 | $15.6M | 0.30% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 1,161,736 | $5.53M | 0.35% | +1,161,736 | New |
| OrbiMed Advisors LLC | 875,297 | $4.17M | 0.05% | −188,821−17.7% | Reduced |
| Morgan Stanley | 873,661 | $4.16M | 0.00% | +150,686+20.8% | Added |
| Walleye Capital LLC | 530,432 | $2.52M | 0.08% | +530,432 | New |
| Laurion Capital Management LP | 500,000 | $2.38M | 0.04% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 331,048 | $1.58M | 0.45% | −300,000−47.5% | Reduced |
| Kingdon Capital Management, L.L.C. | 325,000 | $1.55M | 0.23% | −75,000−18.8% | Reduced |
| Bank Julius Baer & Co. Ltd, Zurich | 197,607 | $941.0K | 0.01% | 00.0% | Unchanged |
| Invesco Ltd. | 159,396 | $759.0K | 0.00% | +159,396 | New |
| Gyon Technologies Capital Management, LP | 100,706 | $479.0K | 0.09% | +100,706 | New |
| Renaissance Technologies LLC | 100,400 | $478.0K | 0.00% | +17,310+20.8% | Added |
| FNY Investment Advisers, LLC | 100,000 | $476.0K | 0.26% | −218,000−68.6% | Reduced |
| Raymond James Financial Services Advisors, Inc. | 95,674 | $455.0K | 0.00% | +81,786+588.9% | Added |
| Franklin Street Advisors Inc | 75,100 | $357.0K | 0.03% | 00.0% | Unchanged |
| Kingsview Wealth Management, LLC | 71,870 | $342.0K | 0.01% | +71,870 | New |
| Birchview Capital, LP | 70,000 | $333.0K | 0.21% | 00.0% | Unchanged |
| Raymond James & Associates | 65,542 | $312.0K | 0.00% | +55,123+529.1% | Added |
| Two Sigma Investments, LP | 60,169 | $286.0K | 0.00% | +49,099+443.5% | Added |
| Citadel Advisors LLC | 56,074 | $267.0K | 0.00% | +56,074 | New |
| Boothbay Fund Management, LLC | 33,229 | $158.0K | 0.01% | −30,112−47.5% | Reduced |
| Marquette Asset Management, LLC | 33,215 | $158.0K | 0.03% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 27,414 | $130.0K | 0.00% | −10,103−26.9% | Reduced |
| D. E. Shaw & Co., Inc. | 27,053 | $129.0K | 0.00% | +27,053 | New |
| IPG Investment Advisors LLC | 25,900 | $124.0K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 18,991 | $90.0K | 0.00% | 00.0% | Unchanged |
| Pacifica Partners Inc. | 20,585 | $80.0K | 0.05% | 00.0% | Unchanged |
| Millennium Management LLC | 13,864 | $66.0K | 0.00% | −32,216−69.9% | Reduced |
| ETF Managers Group, LLC | 13,354 | $59.0K | 0.00% | −2,780−17.2% | Reduced |
| Commonwealth Equity Services, LLC | 10,100 | $48.0K | 0.00% | +10,100 | New |
| Steward Partners Investment Advisory, LLC | 4,800 | $23.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,492 | $21.0K | 0.00% | −523−10.4% | Reduced |
| Cutler Group LP | 2,800 | $13.0K | 0.00% | +2,800 | New |
| BlackRock Inc. | 2,047 | $10.0K | 0.00% | −5,372−72.4% | Reduced |
| JPMorgan Chase & Co | 992 | $5.00K | 0.00% | +383+62.9% | Added |
| Harbour Investments, Inc. | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 231 | $1.00K | 0.00% | +231 | New |
| FinTrust Capital Advisors, LLC | 100 | $0 | 0.00% | +100 | New |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −600,000−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −551,918−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −26,016−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −22,553−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −10,548−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,846−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −776−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |